"Foscarnet" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
| Descriptor ID |
D017245
|
| MeSH Number(s) |
D02.241.081.018.677.250 D02.705.429.875.500
|
| Concept/Terms |
Foscarnet Sodium- Foscarnet Sodium
- Sodium, Foscarnet
- Foscarnet Trisodium Salt
- Trisodium Salt, Foscarnet
- Foscarnet Sodium Hexahydrate
- Hexahydrate, Foscarnet Sodium
- Sodium Hexahydrate, Foscarnet
- Trisodium Phosphonoformate
- Phosphonoformate, Trisodium
|
Below are MeSH descriptors whose meaning is more general than "Foscarnet".
Below are MeSH descriptors whose meaning is more specific than "Foscarnet".
This graph shows the total number of publications written about "Foscarnet" by people in this website by year, and whether "Foscarnet" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Foscarnet" by people in Profiles.
-
Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010 Oct; 23(4):689-712.
-
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol. 2004 May; 65(5):403-9.
-
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis. 2003 Mar 01; 187(5):777-84.
-
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection. Transpl Infect Dis. 2002 Dec; 4(4):189-94.
-
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999 Sep 27; 68(6):814-25.
-
Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob Agents Chemother. 1999 Jun; 43(6):1500-2.
-
A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis. 1992 Oct; 166(4):904-7.